CannabisNews420.com – Cannabis/Marijuana Industry News
SAN DIEGO, March 12, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its portfolio of companies, including HempMeds® and Kannaway®, has officially donated $2 million in cannabidiol (CBD) products to ECHO Connection since 2017.
ECHO Connection is a non-profit organization that aims to educate and support those pursuing cannabinoids for their therapeutic benefits in a trustworthy, safe environment. The organization strives to offer charitable support to ease the burden on families of children with disabilities or special needs. Additionally, ECHO connects families in need with doctors that can help them through an individualized comprehensive approach consisting of education and collaboration.
“While CBD has become an emerging and accelerating market in the overall ‘cannabis arena,’ our company must remember that we were founded with a goal of helping those in need through the health and wellness benefits of CBD,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. “We are grateful for ECHO Connection’s amazing work. Donating to its cause keeps us humble and close to our roots.”
The Company has been donating its flagship CBD product line, Real Scientific Hemp Oil (RSHO) to ECHO Connection since 2017 and works closely alongside the organization to help raise awareness for its charitable efforts.
“ECHO Connection would not be able to help all of the families we do without Medical Marijuana, Inc.’s CBD product donations,” said Andrea Barnes, President of ECHO Connection. “Two million dollars in CBD product donations is more than any other non-profit in the U.S. has reported and our staff and families in need feel the Company’s support every day.”
To learn more about ECHO Connection, visit https://echoconnection.org/.
About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.